Home
Products
Learn
About
Pricing
Log In
PYXS
Asset Logo

PYXIS ONCOLOGY, INC.

🇺🇸 NYSE/NASDAQ

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-26.20%
Annual Growth

4 years average annual capital growth

🌏

6
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Pyxis Oncology, Inc. is a clinical-stage company focused on developing therapeutics to target difficult-to-treat cancers. The Company is building therapeutics that hold the potential for mono and combination therapies. Its clinical program portfolio includes micvotobart pelidotin (MICVO), PYX-106, Sotigalimab (PYX-107), PYX-203, PYX-102, and APX601. The Company’s lead product candidate, MICVO, is an antibody-drug conjugate (ADC) that targets Extradomain-B Fibronectin (EDB+FN), a non-cellular structural component of the tumor extra-cellular matrix (ECM). MICVO is designed to generate a multi-pronged attack on difficult-to-treat cancers by directly killing cancer cells, reducing ECM density, inhibiting tumor angiogenesis and mobilizing an anti-tumor immune response. The Company’s ADC, MICVO, consists of human Immunoglobulin G1 (IgG1) and is site-specifically conjugated with a cleavable linker and a microtubule inhibitor (optimized auristatin) payload.

📈 Performance

Price History*

-92.70%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.97

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in PYXS

6

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

78 weeks

💵 Average investment amount

$351

Last time a customer invested in PYXS

68 days
PYXS investor breakdown
💵 Income of investors

More than 200k

150k - 200k

14%

100k - 150k

43%

50k - 100k

29%

Less than 50k

14%
👶 Age of investors

18 - 25

26 - 34

33%

35 - 90

67%
🙋 Legal gender of investors

Female

67%

Male

33%

Pearlers who invest in PYXS also invest in...

Apple, Inc.

AAPL

🙌 Performance (5Yr p.a)

36.91%

📊 Share price

$196.98 USD

📈 HIGH PRICE GROWTH

Find Out More

🙌 Performance (5Yr p.a)

17.41%

📊 Share price

$483.90 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

263.06%

📊 Share price

$101.49 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

271.06%

📊 Share price

$241.37 USD

🙌 Performance (5Yr p.a)

556.35%

📊 Share price

$172.61 USD

Want more shares? Try these...

🙌 Performance (5Yr p.a)

-2.59%

📊 Share price

$22.51 USD

📊 Share price

$0.32 USD
Compare
Add to watchlist